Long-term cardiovascular and non-cardiovascular mortality in women and men with type 1 and type 2 diabetes mellitus: a 30-year follow-up in Switzerland.

BACKGROUND While studies from other countries have shown an excess mortality in diabetic individuals when compared with the general population, comparable long-term data is not available for Switzerland. AIMS To assess gender-specific cardiovascular and non-cardiovascular mortality of patients with type 1 and type 2 diabetes compared with the general Swiss population between 1974 and 2005. DESIGN 533 patients (225 type 1, 308 type 2 diabetes, 52.2% men) were followed for 30 years (10349 person-years). RESULTS Diabetic patients had an increased all-cause mortality compared with the general population (SMR [95% CI] 3.8 [3.5-4.3]). Standardised mortality ratio (SMR) was higher for type 1 compared with type 2 diabetic patients (4.5 [3.8-5.3] vs 3.5 [3.1-4.0], p = 0.032). For cardiovascular and non-cardiovascular deaths SMRs were 5.6 (95% CI 4.8-6.6) and 2.7 (2.3-3.1) and did not differ according to type of diabetes. SMRs for all-cause and cardiovascular mortality were significantly higher in women compared with men in type 1 (p <0.05 and p <0.01) and type 2 diabetes (p <0.001 and p <0.01). In both types of diabetes, SMRs significantly decreased during the last two decades (p for trend 0.004 and 0.002). CONCLUSIONS Patients with type 1 and type 2 diabetes had an increased long-term mortality compared with the general Swiss population. Excess mortality was higher in type 1 compared with type 2 diabetes and in women compared with men for both types of diabetes, but steadily decreased over the last two decades.

[1]  K. Borch-Johnsen,et al.  The Danish National Diabetes Register: trends in incidence, prevalence and mortality , 2008, Diabetologia.

[2]  C. Mantzoros,et al.  Sex Disparities in the Treatment and Control of Cardiovascular Risk Factors in Type 2 Diabetes , 2008, Diabetes Care.

[3]  Shih-Yi Lin,et al.  Predictors of mortality in hospitalized diabetic patients: A 7-year prospective study. , 2008, Diabetes research and clinical practice.

[4]  C. Florkowski,et al.  All-cause mortality in insulin-treated diabetic patients: a 20-year follow-up. , 2008, Diabetes research and clinical practice.

[5]  C. Florkowski,et al.  Cause-specific mortality in insulin-treated diabetic patients: a 20-year follow-up. , 2008, Diabetes research and clinical practice.

[6]  C. Castell,et al.  Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989 , 2007, Diabetologia.

[7]  M. Zwahlen,et al.  QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up , 2006, Diabetologia.

[8]  M. Zwahlen,et al.  Apolipoprotein B as a long‐term predictor of mortality in type 1 diabetes mellitus: a 15‐year follow up , 2006, Journal of internal medicine.

[9]  D. Kromhout,et al.  Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. , 2006, European heart journal.

[10]  L. Nyström,et al.  Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden , 2006, Diabetologia.

[11]  A. Krolewski,et al.  Mortality from cardiovascular diseases among diabetics , 1977, Diabetologia.

[12]  C. Tseng.  Mortality and causes of death in a national sample of diabetic patients in Taiwan. , 2004, Diabetes care.

[13]  K. Bloch,et al.  Mortality and predictors of mortality in a cohort of Brazilian type 2 diabetic patients. , 2004, Diabetes care.

[14]  H. Bilo,et al.  Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: A prospective population-based study in The Netherlands (ZODIAC-1) , 2002, European Journal of Epidemiology.

[15]  P. Hougaard,et al.  Epidemiological studies of diabetes mellitus in Denmark: 5. Mortality and causes of death among insulin-treated diabetic patients , 1984, Diabetologia.

[16]  G. Panzram,et al.  Prognosis of diabetes mellitus in a geographically defined population , 1981, Diabetologia.

[17]  P. Diem,et al.  Effects of alcohol consumption on mortality in patients with Type 2 diabetes mellitus , 2003, Diabetologia.

[18]  A. J. Swerdlow,et al.  Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes , 2003, Diabetologia.

[19]  D. Kromhout,et al.  Evolution of all-causes and cardiovascular mortality in the age-group 75-84 years in Europe during the period 1970-1996; a comparison with worldwide changes. , 2002, European heart journal.

[20]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[21]  H. Keen,et al.  Mortality and causes of death in the WHO multinational study of vascular disease in diabetes , 2001, Diabetologia.

[22]  G. Pennello,et al.  Cause-specific mortality in a cohort of patients with diabetes mellitus: a population-based study in Sweden. , 2001, Journal of clinical epidemiology.

[23]  C. Florkowski,et al.  Predictors of mortality from type 2 diabetes mellitus in Canterbury, New Zealand; a ten-year cohort study. , 2001, Diabetes research and clinical practice.

[24]  R. Bilous,et al.  Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study , 2001, BMJ : British Medical Journal.

[25]  J. Peters,et al.  Relationship between diabetes and mortality: a population study using record linkage. , 2000, Diabetes care.

[26]  E. Feskens,et al.  Saturated fat, vitamin C and smoking predict long-term population all-cause mortality rates in the Seven Countries Study. , 2000, International journal of epidemiology.

[27]  F. Gutzwiller,et al.  [Development of mortality in Switzerland since 1950. I. International comparison and differences in sex, age and nationality]. , 1999, Schweizerische medizinische Wochenschrift.

[28]  R. de Marco,et al.  Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. , 1999, Diabetes care.

[29]  G. Sundkvist,et al.  Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry. , 1999, Diabetes care.

[30]  K. Narayan,et al.  Causes of death and associated factors among patients with non-insulin-dependent diabetes mellitus in Taipei, Taiwan. , 1999, Diabetes research and clinical practice.

[31]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[32]  A. Reunanen,et al.  Mortality in a large population-based cohort of patients with drug-treated diabetes mellitus. , 1998, American journal of public health.

[33]  F. Nuttall,et al.  Cardiovascular Events and Correlates in the Veterans Affairs Diabetes Feasibility Trial Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes , 1997 .

[34]  D Kromhout,et al.  Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe , 1997 .

[35]  A. Swerdlow,et al.  Mortality during 25 years of follow-up of a cohort with diabetes. , 1996, International journal of epidemiology.

[36]  J. L. Botha,et al.  Insulin treated diabetes mellitus: causes of death determined from record linkage of population based registers in Leicestershire, UK. , 1995, Journal of epidemiology and community health.

[37]  D Kromhout,et al.  Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. , 1995, Archives of internal medicine.

[38]  S. Julious,et al.  Mortality in Diabetic Subjects: An Eleven‐year Follow‐up of a Community‐based Population , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[39]  D. Rogers,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus , 1994 .

[40]  D. Clayton,et al.  Statistical Models in Epidemiology , 1993 .

[41]  M. Knuiman,et al.  An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model. , 1992, American journal of epidemiology.

[42]  R. Klein,et al.  Cause-specific mortality in a population-based study of diabetes. , 1991, American journal of public health.

[43]  E. Barrett-Connor,et al.  Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. , 1991, JAMA.

[44]  E. Jutzi,et al.  Trends in mortality rates in the diabetic population of the GDR. , 2009, Experimental and clinical endocrinology.

[45]  Long-term correction of hyperglycemia and progression of retinopathy in insulin dependent diabetes. A five-year randomized prospective study. , 1988, Diabetes research.

[46]  L. Merenmies,et al.  Continuous insulin infusion therapy and retinopathy in patients with type I diabetes. , 1987, Acta endocrinologica.

[47]  K. Dahl-Jørgensen,et al.  Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. , 1986, British medical journal.

[48]  D. Wagener,et al.  The Pittsburgh Insulin-dependent Diabetes Mellitus (IDDM) Morbidity and Mortality Study: Case-Control Analyses of Risk Factors for Mortality , 1985, Diabetes Care.

[49]  H. Keen,et al.  Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. , 1985, The New England journal of medicine.

[50]  L. Kuller,et al.  The Pittsburgh Insulin-dependent Diabetes Mellitus (IDDM) Morbidity and Mortality Study: Mortality Results , 1984, Diabetes.

[51]  J. Herman,et al.  [Vascular diseases in 534 Swiss diabetics within the scope of a multinational study]. , 1983, Klinische Wochenschrift.

[52]  R. C. Turner,et al.  PREVENTION OF DETERIORATION OF RENAL AND SENSORY-NERVE FUNCTION BY MORE INTENSIVE MANAGEMENT OF INSULIN-DEPENDENT DIABETIC PATIENTS A Two-year Randomised Prospective Study , 1983, The Lancet.

[53]  Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report. , 1982, Diabetes.

[54]  D L McGee,et al.  Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study , 1979, Diabetes Care.

[55]  H. Keen,et al.  The WHO Multinational Study of Vascular Disease in Diabetes: 1. General Description , 1979, Diabetes Care.

[56]  T. Deckert,et al.  Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications. , 1978, Diabetologia.

[57]  L. Elveback,et al.  Diabetes Mellitus: Incidence, Prevalence, Survivorship, and Causes of Death in Rochester, Minnesota, 1945–1970 , 1976, Diabetes.

[58]  H. H. Marks.  LONGEVITY AND MORTALITY OF DIABETICS. , 1965, American journal of public health and the nation's health.